Intuitive Surgical, Inc. (NASDAQ:ISRG) Stake Boosted by Huntington National Bank

Huntington National Bank increased its holdings in Intuitive Surgical, Inc. (NASDAQ:ISRG - Free Report) by 3.5% in the fourth quarter, according to the company in its most recent Form 13F filing with the Securities & Exchange Commission. The firm owned 287,013 shares of the medical equipment provider's stock after purchasing an additional 9,636 shares during the period. Intuitive Surgical accounts for 1.1% of Huntington National Bank's investment portfolio, making the stock its 23rd biggest position. Huntington National Bank owned about 0.08% of Intuitive Surgical worth $149,809,000 as of its most recent SEC filing.

Several other institutional investors have also recently added to or reduced their stakes in ISRG. Atala Financial Inc acquired a new position in shares of Intuitive Surgical during the 4th quarter valued at about $25,000. Berbice Capital Management LLC purchased a new stake in Intuitive Surgical in the fourth quarter valued at approximately $26,000. BankPlus Trust Department acquired a new position in Intuitive Surgical during the fourth quarter worth approximately $28,000. Summit Securities Group LLC purchased a new position in Intuitive Surgical during the fourth quarter worth approximately $30,000. Finally, Kohmann Bosshard Financial Services LLC acquired a new position in shares of Intuitive Surgical in the 4th quarter valued at $31,000. 83.64% of the stock is currently owned by institutional investors and hedge funds.

Insiders Place Their Bets

In other Intuitive Surgical news, Director Amal M. Johnson sold 4,635 shares of the firm's stock in a transaction on Tuesday, January 28th. The shares were sold at an average price of $566.60, for a total transaction of $2,626,191.00. Following the completion of the transaction, the director now directly owns 12,275 shares of the company's stock, valued at $6,955,015. This trade represents a 27.41 % decrease in their position. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which is available at the SEC website. Also, EVP Robert Desantis sold 11,545 shares of the company's stock in a transaction dated Thursday, March 13th. The shares were sold at an average price of $499.22, for a total transaction of $5,763,494.90. Following the completion of the sale, the executive vice president now owns 5,224 shares in the company, valued at approximately $2,607,925.28. This trade represents a 68.85 % decrease in their position. The disclosure for this sale can be found here. Insiders have sold 33,754 shares of company stock worth $17,691,621 in the last three months. 0.70% of the stock is owned by insiders.

Remove Ads

Analyst Upgrades and Downgrades

Several research analysts recently weighed in on the company. Bernstein Bank increased their target price on Intuitive Surgical from $655.00 to $700.00 and gave the stock an "overweight" rating in a research report on Monday, January 27th. UBS Group raised their price objective on Intuitive Surgical from $500.00 to $560.00 and gave the stock a "neutral" rating in a report on Monday, January 27th. Wells Fargo & Company boosted their target price on Intuitive Surgical from $630.00 to $687.00 and gave the stock an "overweight" rating in a report on Friday, January 24th. Stifel Nicolaus raised their price target on shares of Intuitive Surgical from $525.00 to $610.00 and gave the company a "buy" rating in a report on Thursday, December 5th. Finally, CICC Research began coverage on shares of Intuitive Surgical in a research note on Monday, January 27th. They set a "neutral" rating and a $550.00 price objective for the company. One research analyst has rated the stock with a sell rating, five have given a hold rating and fifteen have assigned a buy rating to the company's stock. According to data from MarketBeat, the company currently has a consensus rating of "Moderate Buy" and a consensus target price of $611.86.

Intuitive Surgical Stock Performance

Shares of NASDAQ ISRG traded down $43.03 during midday trading on Friday, reaching $451.58. 4,106,917 shares of the company's stock were exchanged, compared to its average volume of 1,542,647. Intuitive Surgical, Inc. has a 52-week low of $364.17 and a 52-week high of $616.00. The business's fifty day moving average price is $545.18 and its two-hundred day moving average price is $532.30. The stock has a market capitalization of $160.84 billion, a PE ratio of 70.45, a price-to-earnings-growth ratio of 5.85 and a beta of 1.55.

Intuitive Surgical Company Profile

Intuitive Surgical, Inc develops, manufactures, and markets products that enable physicians and healthcare providers to enhance the quality of and access to minimally invasive care in the United States and internationally. The company offers the da Vinci Surgical System that enables complex surgery using a minimally invasive approach; and Ion endoluminal system, which extends its commercial offerings beyond surgery into diagnostic procedures enabling minimally invasive biopsies in the lung.